Parthenon LLC’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,877
Closed -$216K 134
2025
Q3
$216K Sell
2,877
-137
-5% -$10.2K 0.02% 123
2025
Q2
$223K Sell
3,014
-670
-18% -$46.6K 0.03% 119
2025
Q1
$297K Sell
3,684
-25
-0.7% -$2.15K 0.04% 107
2024
Q4
$290K Sell
3,709
-122
-3% -$10.4K 0.04% 105
2024
Q3
$360K Sell
3,831
-14
-0.4% -$1.18K 0.04% 104
2024
Q2
$300K Sell
3,845
-135
-3% -$11K 0.04% 102
2024
Q1
$362K Sell
3,980
-27
-0.7% -$2.25K 0.05% 96
2023
Q4
$310K Sell
4,007
-100
-2% -$7K 0.04% 102
2023
Q3
$279K Sell
4,107
-1,638
-29% -$119K 0.04% 103
2023
Q2
$467K Sell
5,745
-4,689
-45% -$374K 0.07% 90
2023
Q1
$856K Buy
+10,434
New +$745K 0.13% 74

Other funds holding GEHC

Parthenon LLC's GEHC Position: Q4 2025 in Review

Parthenon LLC sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 2,877 shares — an estimated $216K sold.

Parthenon LLC first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $856K in Q1 2023. 1,334 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Parthenon LLC reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Parthenon LLC sold 2,877 GE HealthCare shares in Q4 2025, an estimated $216K.
  • Parthenon LLC first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Parthenon LLC's GE HealthCare position peaked at $856K in Q1 2023.
  • 1,334 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Parthenon LLC's 13F filing for Q4 2025, filed 23 Jan 2026.